dialysis access
Conditions
Interventions
Treatment group:folic acid, 10mg/tid
Control group:placebo
Sponsors
Shandong Provincial Qianfoshan Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Male or female =18 years old; 2. Patients diagnosed with uremia (GFR<15ml/(ml/min/1.73m2)); 3. Accepting the hemodialysis; 4. Accepting end-to-side in upper limb arteriovenous fistula for dialysis access; 5. Signed the informed consent form prior to the study participation.;Inclusion criteria: 1. Male or female =18 years old; 2. Patients diagnosed with uremia (GFR<15ml/(ml/min/1.73m2)); 3. Accepting the hemodialysis; 4. Accepting end-to-side in upper limb arteriovenous fistula for dialysis access; 5. Signed the informed consent form prior to the study participation.;Inclusion criteria: 1. Male or female =18 years old; 2. Patients diagnosed with uremia (GFR<15ml/(ml/min/1.73m2)); 3. Accepting the hemodialysis; 4. Accepting end-to-side in upper limb arteriovenous fistula for dialysis access; 5. Signed the informed consent form prior to the study participation.;Inclusion criteria: 1. Male or female =18 years old; 2. Patients diagnosed with uremia (GFR<15ml/(ml/min/1.73m2)); 3. Accepting the hemodialysis; 4. Accepting end-to-side in upper limb arteriovenous fistula for dialysis access; 5. Signed the informed consent form prior to the study participation.;Inclusion criteria: 1. Male or female =18 years old; 2. Patients diagnosed with uremia (GFR<15ml/(ml/min/1.73m2)); 3. Accepting the hemodialysis; 4. Accepting end-to-side in upper limb arteriovenous fistula for dialysis access; 5. Signed the informed consent form prior to the study participation.
Exclusion criteria
Exclusion criteria: Patients with malignant disease; Active autoimmune diseases; Acute or chronic infection disease, such as tuberculosis; Severe cardiovascular, brain, liver, or hematopoietic system disease; Serious gastrointestinal disease which affect drug absorption, such as active ulcer, chronic diarrhea, post gastrointestinal surgery etc. Women in pregnancy or lactation; Can not be partners, such as the mentally ill; With alcohol or drug abuse; Enrolled in other trials; Any other conditions that researchers think not suitable for this experiment.;Exclusion criteria: Patients with malignant disease; Active autoimmune diseases; Acute or chronic infection disease, such as tuberculosis; Severe cardiovascular, brain, liver, or hematopoietic system disease; Serious gastrointestinal disease which affect drug absorption, such as active ulcer, chronic diarrhea, post gastrointestinal surgery etc. Women in pregnancy or lactation; Can not be partners, such as the mentally ill; With alcohol or drug abuse; Enrolled in other trials; Any other conditions that researchers think not suitable for this experiment.;Exclusion criteria: Patients with malignant disease; Active autoimmune diseases; Acute or chronic infection disease, such as tuberculosis; Severe cardiovascular, brain, liver, or hematopoietic system disease; Serious gastrointestinal disease which affect drug absorption, such as active ulcer, chronic diarrhea, post gastrointestinal surgery etc. Women in pregnancy or lactation; Can not be partners, such as the mentally ill; With alcohol or drug abuse; Enrolled in other trials; Any other conditions that researchers think not suitable for this experiment.;Exclusion criteria: Patients with malignant disease; Active autoimmune diseases; Acute or chronic infection disease, such as tuberculosis; Severe cardiovascular, brain, liver, or hematopoietic system disease; Serious gastrointestinal disease which affect drug absorption, such as active ulcer, chronic diarrhea, post gastrointestinal surgery etc. Women in pregnancy or lactation; Can not be partners, such as the mentally ill; With alcohol or drug abuse; Enrolled in other trials; Any other conditions that researchers think not suitable for this experiment.;Exclusion criteria: Patients with malignant disease; Active autoimmune diseases; Acute or chronic infection disease, such as tuberculosis; Severe cardiovascular, brain, liver, or hematopoietic system disease; Serious gastrointestinal disease which affect drug absorption, such as active ulcer, chronic diarrhea, post gastrointestinal surgery etc. Women in pregnancy or lactation; Can not be partners, such as the mentally ill; With alcohol or drug abuse; Enrolled in other trials; Any other conditions that researchers think not suitable for this experiment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| dysfunction of AVF measured by vascular ultrasound; | — |
Countries
China
Contacts
Public ContactXu Dongmei;Xu Dongmei;Xu Dongmei;Xu Dongmei;Xu Dongmei ;;;;
Shandong Provincial Qianfoshan Hospital;Shandong Provincial Qianfoshan Hospital;Shandong Provincial Qianfoshan Hospital;Shandong Provincial Qianfoshan Hospital;Shandong Provincial Qianfoshan Hospital
Outcome results
None listed